Student Council Symposium 2016
The Student Council Symposium is a forum for students, post docs, and young researchers in the fields of Computational Biology and Bioinformatics. Participants will have the opportunity to present their work to an international audience, build a network within the computational biology community and develop important soft skills in an environment that fosters exchange of ideas and knowledge.
The Student Council Symposium 2016 (SCS2016) will be held on Friday, July 8, 2016 at ISMB 2016 in Orlando, Florida. The program will include an ice-breaking event, two (2) keynotes, oral sessions and a poster session. To provide students with more opportunity to communicate orally about their work the program will also include a session of flash presentations. These fast-paced, 5 minute presentations are designed to redirect interested attendees to your poster and network.
For full details visit: http://symposium.iscbsc.org
Student Council Symposium | |
---|---|
February 1, 2016 | Abstract Call Opens |
April 22, 2016 | Abstract Call Closes |
May 13, 2016 | Abstract Acceptance Notification |
May 23, 2016 | Student Council Travel Fellowship Deadline |
May 27, 2016 | Late Poster Submission Deadline |
June 3, 2016 | Student Council Travel Fellowship Acceptance Notification |
July 8, 2016 | Student Council Symposium |
Birds of a Feather (BoF) Schedule
BOF01 - Topic: Visualization of Biological Data
Leader: Nils Gehlenborg
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Affiliation: Harvard Medical School
Day: Monday, July 16, 5:30 - 6:30 pm
Room: 104A
Description:
Visualization is one of the primary ways that biologists interact with their data, however today’s systems are inadequate for many high-throughput data sets. We invite those interested to a discussion of recent and ongoing community efforts aimed at improving integration, effectiveness, and usability of visualization in biology (e.g. http://biovis.net and http://vizbi.org).
BOF02 - Topic: Curriculum Guidelines for Bioinformatics and Computational Biology (An Open Forum of the Curriculum Task Force of the ISCB Education Committee)
Leader: Lonnie Welch
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Affiliation: Ohio University
Day: Monday, July 16, 5:30 - 6:30 pm
Room: 104B
Description:
The Curriculum Task Force of the ISCB Education Committee will hold an open forum to discuss bioinformatics curriculum guidelines. Participants will consider curricular implications of the task force’s surveys of career opportunities, hiring practices of bioinformatics core facility directors, and existing curricula. The forum seeks inputs from all interested individuals.
BOF03 - Topic: The future of data capture in scientific publishing
Leader: Gary Bader
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Affiiation: University of Toronto
Day: Monday, July 16, 5:30 - 6:30 pm
Room: 104C
Description:
Wouldn't it be great if publication authors could digitize their scientific results when they submit their paper for peer-review? Software systems are needed to enable this, composed of automatic text mining systems and intuitive user interfaces that make data entry fun and easy. This session aims to bring together text miners, software developers, database groups and journal editors to discuss this aspect of the future of scientific publication. (Topic by Chris Sander, Gary Bader)
BOF04 - Topic: The Next Critical Assessment of Function Annotations
Leader: Iddo Friedberg
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Affiliation: Miami University
Day: Monday, July 16, 5:30 - 6:30 pm
Room: 202A
Description:
Less than 2% of protein sequences are annotated manually, and less than 1% by experiments. With the advent of the $1000 genome, the analysis typically costs over $50,000. The Critical Assessment of Function Annotation (CAFA) is an ongoing effort to assess and improve computational function prediction methods. CAFA 2011 was highly successful, engaging 30 groups from 14 countries presenting 50 different algorithms. We are looking to engage more people in the next CAFA as predictors, assessors and judges. This is a great opportunity to join a large international effort and learn about cutting-edge technologies which are used in gene and genome annotation.
ISMB 2012 - Tutorials
Location: Hyatt Regency Long Beach Hotel (adjacent to Long Beach Convention Center)
Room: Regency Ballroom E/F
Keynote Presentations
ISMB 20th Anniversary Keynote
Presentation Title: Seeing forward by looking back
Room: Grand Ballroom
Sunday, July 15 - 9:00 a.m. - 10:00 a.m.

University of California, Irvine
United States
Lawrence Hunter (KN1)
University of Colorado School of Medicine, Denver
United States
Additional Information: Show/Hide
Abstract
The 20 ISMB conferences make intriguing markers for the evolution of our field. From our origins in artificial intelligence (few these days even know that the “IS” in “ISMB” stands for “intelligent systems”) to today’s sprawling conference covering all aspects of computation applied to biology, the people and papers of ISMB can be used to chart the evolution of our field. In this reflection, we will both look back at where we have been, and try extrapolate to where the field may be heading next.
Ph.D., is a Professor in the Department of Computer Science at the University of California, Irvine. He received an undergraduate degree in mathematics from Reed College, a Ph.D. in Artificial Intelligence from MIT, and also holds graduate degrees in computer science and in electrical engineering from MIT. His post-doctoral work was supervised by Patrick Winston and Temple Smith.
Dr. Lathrop's research interests involve applying intelligent systems and advanced computation to problems and data from molecular biology. He co-founded Arris Pharmaceutical Corp. (now Celera Therapeutics) and Coda Genomics, Inc. (now Verdezyne). His research has appeared on the covers of Communications of the ACM, Journal of Molecular Biology, and AI Magazine. He has received a Best Paper Award from the ACM/IEEE Design Automation Conference, an Innovative Application Award from the AAAI/IAAI Conference, a Best Paper Award from the Genome Informatics Conference, and the Professor of the Year award from the UCI Celebration of Teaching. He is a co-inventor of two US patents. He was a founding officer, and is currently a member of the Board of Directors, of the International Society for Computational Biology.
Dr. Lawrence Hunter is the Director of the Computational Bioscience Program and of the Center for Computational Pharmacology at the University of Colorado School of Medicine, and a Professor in the departments of Pharmacology and Computer Science (Boulder). He received his Ph.D. in computer science from Yale University in 1989, and then spent more than 10 years at the National Institutes of Health, ending as the Chief of the Molecular Statistics and Bioinformatics Section at the National Cancer Institute. He inaugurated two of the most important academic bioinformatics conferences, ISMB and PSB, and was the founding President of the International Society for Computational Biology. Dr. Hunter's research interests span a wide range of areas, from cognitive science to rational drug design. His primary focus recently has been the integration of natural language processing, knowledge representation and machine learning techniques and their application to interpreting data generated by high throughput molecular biology.
ISCB Overton Prize Lecture
Ziv Bar-Joseph (KN2)
Lane Center for Computational Biology and Machine Learning Department
Carnegie Mellon University
United States
Presentation Title: Data integration for understanding dynamic biological systems
Room: Grand Ballroom
Sunday, July 15 – 4:30 p.m. – 5:30 p.m.
Additional Information: Show/Hide
Ziv Bar-Joseph is an Associate Professor in the Lane Center for Computational Biology and the Machine Learning Department at the School of Computer Science at Carnegie Mellon University. His work focuses on the analysis and integration of static and temporal high throughput biological data for systems biology. Based primarily on methods from machine learning, his group develops computational solutions to problems ranging from experimental design to data analysis, pattern recognition and the reconstruction of dynamic biological networks within and across species. More recently he has also worked on improving algorithms for distributed computational networks by relying on our increased understanding of how biological systems operate and what makes them robust and adaptable. Dr. Bar-Joseph has been the co-chair of the RECOMB meeting on Regulatory Networks and Systems Biology in the past two years and he is currently on the editorial board of Bioinformatics. He received his Ph.D. from the Massachusetts Institute of Technology (MIT) and is a recipient of the DIMACS-Celera Genomics Graduate Student Award in Computational Molecular Biology and the NSF CAREER award.
Website: http://www.cs.cmu.edu/~zivbj/
Barbara Wold (KN3)
California Institute of Technology, Pasadena
United States
Presentation Title: Analysis of transcriptome structure and chromatin landscapes
Room: Grand Ballroom
Monday, July 16 – 9:00 a.m. – 10:00 a.m.
Additional Information: Show/Hide
Some key consequences and remaining challenges are highlighted. Recent work by the ENCODE consortium is highlighting integrative analysis of diverse genome-wide chromatin data obtained from multiple cell and tissue types. We show that large self organizing maps (SOMs) are effective for chromatin integration, visualization and mining from the end-user biologist's perspective. An ENCODE chromatin SOM illustrates by showing relationships for cell type specific regulatory elements.
Biography
Barbara Wold is the Bren Professor of Molecular Biology and Director of the Beckman Institute at Caltech. In 2011-2012 she will be on leave at the National Cancer Institute to establish its new Cancer Genomics Center. She began working on genome structure and gene regulation during embryo development for her PhD thesis with Eric Davidson, and developed ways to dissect regulatory DNA elements during postdoctoral work at Columbia in Richard Axel’s laboratory. She returned to Caltech to join the Biology faculty in 1981 where she and her students and collaborators study gene and genome function. Recent foci have been developing and then applying new ways to map the inputs and outputs of gene networks in a genomewide manner using “next generation” DNA sequencing (ChIP-Seq, RNA-Seq, single-cell RNA-Seq etc), and applying these methods to gene works that govern mouse and worm myogenesis, T-cell development, and human brain networks.
ISCB Fellows Keynote
Richard Durbin (KN4)
Wellcome Trust Sanger Institute
Cambridge, United Kingdom
Presentation Title: Progress, challenges and opportunities in population genome sequencing
Room: Grand Ballroom
Monday, July 16 – 4:30 p.m. – 5:30 p.m.
Additional Information: Show/Hide
Abstract:
The dramatic decrease in DNA sequencing costs in the last few years has direct full genome sequence studies of genetic diversity by sequencing multiple individuals. As well as revealing the full genome sequence of a species including variation within the species, rather than just a representative reference sequence, and hence supporting evolutionary and population genetic studies, this also allows phenotype association studies to be extended to all types of genetic variation, not just common variation typed by genotyping chips. However, there are serious
computational complexities in designing studies and analysing the data. These arise both from the random shotgun nature of current sequencing data combined with the repetitive properties of genomes, and from the complex structure of genetic variation arising from mutation, recombination and inheritance, combined of course with the ever-present requirement for efficiency. I will discuss some of the successes in adressing these issues, and some of the outstanding problems, illustrating with results from the 1000 Genomes Project and population sequencing projects from genetic isolates, where we can begin to build a near-complete picture of genetic variation.
Biography
Richard Durbin is joint Head of Human Genetics at The Wellcome Trust Sanger Institute. He has made multiple theoretical and algorithmic contributions to biological sequence analysis, and contributed to the human genome project and development of the Pfam, TreeFam and WormBase data resources. He is currently co-leading the 1000 Genomes Project to produce a deep catalogue of human genetic variation by large scale sequencing, and the UK10K collaboration to extend sequence based genetics to samples with clinically relevant phenotypes, and has renewed interests in genome assembly methods.
Richard has a BA in Mathematics, and a PhD in Biology from Cambridge University. Following postdoctoral research on neural networks at Stanford University, and 6 years at the MRC Laboratory of Molecular at the start of the C.elegans and human genome projects, he moved to the Sanger Institute where he was Head of Informatics from 1992-2006 and Deputy Director from 1997 to 2006. He was elected a Fellow of the Royal Society in 2004 and of ISCB in 2011.
Andrej Sali (KN5)
University of California, San Francisco
United States
Presentation Title: Integrative Structural Biology
Room: Grand Ballroom
Tuesday, July 17 – 9:00 a.m. – 10:00 a.m.
Additional Information: Show/Hide
Abstract
Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, California Institute for Quantitative Biosciences, Mission Bay Byers Hall 508B, 1700 4th Street, University of California, San Francisco, San Francisco, CA 94158-2330, USA
Our broad goal is to contribute to a comprehensive structural characterization of large macromolecular assemblies. Such a characterization is best achieved by hybrid approaches that integrate data from diverse biochemical and biophysical experiments, such as X-ray crystallography, NMR spectroscopy, electron microscopy, immuno-electron microscopy, footprinting, chemical cross-linking, FRET spectroscopy, small angle X-ray scattering, immunoprecipitation, and genetic interactions. Even a coarse structural characterization is often useful to understand how the assembly functions, how it has evolved, and how it could be modulated, in addition to providing a necessary starting point for a higher resolution description.
We formulate the hybrid approach to structure determination as an optimization problem, the solution of which requires three main components: the representation of the assembly, the scoring function, and the optimization method. The ensemble of solutions to the optimization problem embodies the most accurate structural characterization given the available information. The key challenges remain translating experimental data into restraints on the structure of the assembly, combining these spatial restraints into a single scoring function, optimizing the scoring function, and analyzing the resulting ensemble of solutions. Incompleteness and errors in experimental data are treated using inference-based scoring functions that extract the maximum possible information from the data, following a Bayesian approach with minimal assumptions and approximations. Sampling all model structures consistent with the data is often challenging due to the rugged nature of the scoring function landscape and its many local minima; we are developing a multi-scale sampling method that efficiently divides the complete set of degrees of freedom into potentially overlapping subsets, finds optimal and suboptimal solutions for the subsets independently by traditional optimizers or enumeration, and then combines compatible solutions to obtain guaranteed best-scoring solutions for the whole system.
Our methods are implemented in the open source Integrative Modeling Platform (IMP) package (http://salilab.org/imp). IMP is designed to allow mixing and matching of existing modeling components as well as easy adding of new functionality. It supports a wide variety of assembly representations and input data. We also provide infrastructure that encourages and supports contributions from other laboratories.
IMP will be illustrated by its application to the determination of the molecular architectures of the Nuclear Pore Complex, the 26S proteasome, and the Spindle Pole Body.
Russel D, Lasker K, Webb B, Velazquez-Muriel J, Tjioe E, Schneidman-Duhovny D, Peterson B, Sali A. Putting the pieces together: integrative structure determination of macromolecular assemblies. PLoS Biol 10, e1001244, 2012.
Lasker K, Forster F, Bohn S, Walzthoeni T, Villa E, Unverdorben P, Beck F, Aebersold R, Sali A, Baumeister W. Molecular architecture of the 26S proteasome holocomplex determined by an integrative approach. Proc Natl Acad Sci USA 109, 1380-1387, 2012.
F. Alber, F. Förster, D. Korkin, M. Topf, A. Sali. Integrating Diverse Data for Structure Determination of Macromolecular Assemblies. Annual Review of Biochemistry 77, 443-477, 2008.
F. Alber, S. Dokudovskaya, L. Veenhoff, W. Zhang, J. Kipper, D. Devos, A. Suprapto, O. Karni, R. Williams, B.T. Chait, M.P Rout, A. Sali. Determining the architectures of macromolecular assemblies. Nature 450, 683-694, 2007.
Andrej Sali received his BSc degree in chemistry from the University of Ljubljana, Slovenia, in 1987; and his PhD from Birkbeck College, University of London, UK, in 1991, under the supervision of Professor Tom L. Blundell, where he developed the MODELLER program for comparative modeling of protein structures. He was then a postdoc with Professor Martin Karplus at Harvard University as a Jane Coffin Childs Memorial Fund fellow, studying lattice Monte Carlo models of protein folding. From 1995 to 2002, he was first an Assistant Professor and then an Associate Professor at The Rockefeller University. In 2003, he moved to University of California, San Francisco, as a Professor of Computational Biology in the Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, and California Institute for Quantitative Biosciences (QB3). He was a Sinsheimer Scholar (1996), an Alfred P. Sloan Research Fellow (1998), an Irma T. Hirschl Trust Career Scientist (2000), and the recipient of the Zois Award of Science Ambassador of Republic of Slovenia (2007). He is an Editor of Structure and a Founder of Prospect Genomix that merged with Structural Genomix, finally acquired by E. Lilly & Co. Dr. Sali is interested in developing and applying computational methods for determining structures and functions of proteins and their assemblies.
ISCB Senior Scientist Accomplishment Award

Photo Max Brouwers
Stockholm University
Sweden
Presentation Title: The other Third: Coming to grips with membrane proteins
Room: Grand Ballroom
Tuesday, July 17 – 4:30 p.m. – 5:30 p.m.
Additional Information: Show/Hide
Integral membrane proteins account for around 30% of all proteins in most organisms. They are key players (and favored drug targets) in all processes dealing with transport of molecules or ions across cellular membranes, as well as in signal transduction pathways. Yet, our understanding of membrane proteins lags behind that of soluble proteins in almost every respect: biosynthesis, folding, structure, and function. In the past 10 years, however, membrane proteins have progressively moved into the headlines of the molecular life sciences, in a large part thanks to a tight interplay between bioinformatics, computational modeling, and wet-lab work ranging from biophysics to structural biology.
Gunnar von Heijne worked mainly on problems related to protein sorting and membrane protein biogenesis and structure. The work includes both bioinformatics methods development (e.g. methods for prediction of signal peptides and other sorting signals as well as prediction of membrane protein topology) and experimental studies inE. coliand eukaryotic systems. The most important achievements include the discovery of the so-called (-1,-3)-rule (describes signal peptide cleavage sites) and the positive inside rule (describes membrane protein topology), the development of widely used prediction methods (e.g., TopPred, SignalP, TMHMM), and the first quantitative analysis of the energetics of membrane protein assembly in vivo.
Workshops
Workshop 1: Navigating the granting jungle
Workshop 2: Computational Drug Repositioning and Systems Pharmacology
Workshop 3: Bioinformatics Core Facilities
Workshop 4: Workshop on Education in Bioinformatics (WEB 2012) - The Future in Bioinformatics Training
Workshop 5: P2P - From Postdoc To Principal Investigator
Workshop 6: Bioinformatics for Agriculture and Industrial Biotechnology
Many different agencies provide funding for research activities. These exist on national levels, but also fund bi-national or international co-operation. This workshop will help current and future principle investigators from the field of bioinformatics and computational biology to get an overview of funding options and information resources available to find such funding sources. In addition, the workshop will help select those funding schemes that are promising as fitted to the individual situation (career stage, collaborators, etc).
Time
|
Topic
|
Speaker
|
10:45-11:10
|
Overview of funding opportunities from EMBO, NSF, DOE – session 1
|
Katja Linssen, Julie Dickerson, Susan Gregurick
|
11:15-11:40
|
Overview of funding opportunities from EMBO, NSF, DOE – session 2
|
Katja Linssen, Julie Dickerson, Susan Gregurick
|
11:45-12:10
|
Grant writer and reviewer perspectives
|
Russ Altman, Stanford U
Sean Mooney, Buck Institute
|
12:10-12:20 | BIGDATA Program at NSF | Tandy Warnow, Program Director CISE/IIS - download ppt |
12:10-12:40
|
Round Table discussion
|
All Participants
|
Part A. Drug interactions as markers for repurposing opportunities (2:30 p.m. - 2:55 p.m.)
Speaker: Russ B Altman, Stanford University
We have created methods for looking for drug interactions at the molecular and cellular level, as well as through logical analysis of the literature, and data mining of population-based health records. Each of these data sources individually is powerful but biased. When combined, they may yield more robust hypotheses about how drugs may combine to create unexpected response phenotypes, useful for repurposing. We have used molecular methods to propose repurposing for kinases, cellular methods for potentially repurposing parthenolide, and have found synergistic interactions between existing drugs that create responses not associated with either drug alone.
Part B. Can Computational Biology Deliver Systematic Drug Repositioning? (3:00 p.m. - 3:25 p.m.)
Speaker: Pankaj Agarwal, GlaxoSmithKline R&D
Proving that a drug that has seen human patients also works in another indication adds clear value for patients. The question for computational biology is can these predictions be made systematically with precision. We will discuss two recent methods that add to this debate. The first one uses genetics associations (from Genome Wide Association Studies – GWAS) to find new indications for drugs some of which are being validated experimentally. The second one frames the side effects of drugs as pharmacological effects, relies on the observation that many drugs that treat a disease have similar side effects, and then predicts other drugs with similar side effects as potential treatments for the disease.
Part C. Rescuing targeted compounds with combination therapy and protein interactions models (3:30 p.m. - 3:55 p.m.)
Speaker: Yves Lussier, University of Chicago
We hypothesized that unbiased protein interaction network models can unveil non-canonical mechanism of targeted therapy resistance . We identified a FDA approved drug that may sensitize resistant cancer cells by inhibiting the bioinformatically-identified aberrant molecular signals sustaining EGFR pathway activity. This network-targeting therapy, later validated in vitro/in vivo, spawned the development of our NIH Phase II clinical trial. These approaches are scalable to unveil novel interactions with canonical pathways and may apply to identifying novel targets in addition to drug rescue.
Part D. Computational Drup Repositioning and Systems Pharmacology (4:00 p.m. - 4:25 p.m.)
Speakers: Michael Schroeder, TU Dresden, Germany
Phil Bourne, University of California San Diego
Jacob Koehler, Dow AgroSciences
The long standing and problematic notion of designing one drug to specifically act against one target to treat one disease is slowly giving
way to a more systematic systems-based approach broadly defined as systems pharmacology. In a computational sense it is where computational chemistry, bioinformatics, chemoinformatics and systems biology meet. Computational systems pharmacology is translational in that it embraces data from genotype through to electronic health records on patient cohorts. Here, we briefly summarise our experiences and discuss the latest developments leading to new lead compounds and biomarkers, repositioning of existing approved drugs, the use of multiple drug therapies.
Simon Andrews -The Babraham Institute
Fran Lewitter - Whitehead Institute for Biomedical Research
Brent Richter - Partners Healthcare
David Sexton - Baylor College of Medicine
Topic 1: Extracting biological information from diverse data sources
(Talks: 25 minutes, 5 minute break; Open Forum Discussion: 25 minutes, 5 minute break)
Scientists have typically thought of experiments in terms of using a single technology to answer a question. Technologies such as genome wide analyses have generally been performed using a single type of analysis (sequencing, microarray, mass-spec etc). However we are seeing that a complete biological picture of an experimental system can only really be gained by integrating together multiple diverse data types. Increasingly, research departments and projects are beginning to find their sequencing data limits their findings (gene associations are noisy in that the genes identified, once examined closely, usually point to other up/down stream factors) and begin to turn to data and analysis in the domains of network and systems biology. In some fields (eg epigenetics) the need for this type of integration of methylation, histone modification, nucleosome positioning, mass spec and RNA-seq is already present, but the same principle applies to most biological systems. In this session we will aim to look at the practicalities of this type of integration, including success stories, pitfalls and failures and some discussion about the tools available to help.
Part A: "Opportunities & Challenges with Integrating Large-Scale –‘Omics Data."
Speaker: Stephen Turner Bioinformatics Core Director, University of Virginia
This talk will show how to integrate diverse ‘Omics data to provide a fuller picture of biological function and significance of discovered variation.
Part B: "Challenges of integrating and analyzing different genomic data types"
James Cavalcoli (Director, CCDU Bioinformatics Core, University of Michigan)
This talk will focus on the tools available for data integration and how they can be used to provide the scientist with filters to narrow the data space in which they have to search.
Part C: Discussion: Extracting biological information from diverse data sources (11:15 a.m. - 11:40 a.m.)
To be moderated by Jim Cavalcoli, Director, CCDU Bioinformatics Core, University of Michigan and Fran Lewitter, Director of Bioinformatics and Research Computing, Whitehead Institute for Biomedical Research.
Topic 2: Handling the increase of demand and requirements from different sets of users within a core (11:45 a.m. - 12:10 p.m.)
(Talks: 25 minutes, 5 minute break; Open Forum Discussion: 25 minutes, 5 minute break)
Many core facilities deal with diverse sets of users who come with very different needs. Balancing the needs of these different sets of users is a challenging task, which can be compounded by financial, regulatory or political pressures. Common headaches might include the special requirements of users working with clinical samples or for pipelines "translating" from research use to production or even clinical sequencing service. Pressure to transition and concerns of traceability, tracking, and privacy must be addressed. Additionally, external or commercial samples might come with service level agreements, which dictate the level, speed or quality of service required.
Keeping everyone happy in these situations is a potential minefield for a core, so in this session we will hear how some existing facilities have coped with these pressures, and what challenges remain. We will discuss in more detail some of the specific problems, which come with clinical applications since these present an immediate challenge affecting many of the groups.
Part D: Running a Bioinformatics Help Desk: from drawing colorful plasmid maps to working with HiSeq Data
Hans-Rudolf, Friedrich Miescher Institute for Biomedical Research, Switzerland
This talk will focus on the diverse population of investigators who use core services and the difficulty of satisfying all of the competing interests of those users.
Part E: The Challenges of Dealing with Medical Data Reinhard Schneider, University of Luxembourg, Luxembourg
This talk will investigate the increased use of medical sequencing and the challenges this can present to an academic bioinformatics core. There are many regulatory and privacy hurdles that must be navigated by cores, which are not used to satisfying these requirements.
Part F: Discussion: Handling the increase of demand and requirements from different sets of users within a core (12:15 p.m. - 12:40 p.m.)
To be moderated by Brent Richter, Partners Healthcare and David Sexton, Baylor College of Medicine, Human Genome Sequencing Center.
The focus of many bioinformatics training programs is on the translation of the bioinformatics tools and skills needed by their research audience. In parallel, bioinformatics training programs must also keep pace with the advances in technology that support their training efforts, such as computing in the Cloud and web-based learning platforms. There is an even greater need now to keep abreast of such technologies, since many of the newer high-throughput research methods produce such large volumes of data that trying to cover a realistic scenario of data retrieval, handling and manipulation in a classroom environment depends upon enormous computational power to store and handle such data (e.g. NGS course where read alignment involves storage and manipulation of file sizes of 1TB from a single flow cell experiment).
This workshop will consist of presentations on 1) how computing in the Cloud can alleviate the stress of insufficient computational infrastructure, make computationally intensive training programs feasible and be used to further participant skills; 2) how repositories of established, updated tutorials can promote self-directed bioinformatics training and complement onsite training programs; and 3) how the development of e-learning bioinformatics resources and the demand for self-directed learning is changing the focus of face-to-face bioinformatics training programs.
Part A: Bioinformatics training in the clouds (2:30 p.m. - 2:55 p.m.)
Speaker: Francis Ouellette, Canadian Bioinformatics Workshops, Canada
Francis Ouellette will speak on how the Cloud is being used to help run the Informatics for High-throughout Sequencing workshops offered by the Canadian Bioinformatics Workshops.
Part B: Bioinformatics education outside of a different box (3:00 p.m. - 3:25 p.m.)
Speaker: Trey Lathe, OpenHelix, United States
Trey Lathe will speak on how a self-directed model of bioinformatics training is pushing demand for a repository of high quality, tool specific tutorials.
Part C: Train online: reflections on the early days (3:30 p.m. - 3:55 p.m.)
Speaker: Cath Brooksbank, EMBL-EBI United Kingdom
Cath Brooksbank will speak on how demand for self-directed web based learning resources in bioinformatics is fueling the development of e-learning bioinformatics resources and changing the focus of face-to-face bioinformatics training programs.
Part D: Panel Discussion: Workshop on Education in Bioinformatics (4:00 p.m. - 4:25 p.m.)
Speaker: Michelle Brazas, Ontario Institute for Cancer Research, Canada
Invited presentations will be followed by a panel discussion (moderated by Michelle Brazas) with the objective to project how new technologies can be incorporated into current bioinformatics training programs and how new technologies are changing the landscape of bioinformatics training.
Speaker: Philip E. Bourne Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego
All speakers
Abstract:
The aim of this workshop is to help build an ISMB community for those working on data from the genomes of species relevant to food security, energy security and industrial biotechnology. Increasing our food and energy security through sustainable agriculture and the exploitation of biotechnology are global challenges. These challenges are rising up the political and economic agenda in many countries and there are many calls for increased investment in agricultural research. The genomics revolution is only now starting to have a real impact in agricultural research and we believe that a growing and vibrant Bioinformatics community will be essential to the delivery of improved crop varieties, crop protection technologies and new biotechnological processes
Speaker: Timothy Swaller, Director of Information Technology and Genomics, Ceres, Inc. , United States